Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

Go back to Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
(NASDAQ: INBS) Delayed: 2.20 -0.03 (1.35%)
Previous Close $2.23    52 Week High
Open $2.25    52 Week Low
Day High $2.29    P/E N/A 
Day Low $2.17    EPS
Volume 25,509       

(NASDAQ: INBS) Delayed: 2.20 -0.03 (1.35%)
Previous Close $2.23    52 Week High
Open $2.25    52 Week Low
Day High $2.29    P/E N/A 
Day Low $2.17    EPS
Volume 25,509